Literature DB >> 31670340

Non-viral delivery of CRISPR/Cas9 complex using CRISPR-GPS nanocomplexes.

Piyush K Jain1, Justin H Lo2, Santosh Rananaware3, Marco Downing3, Apekshya Panda4, Michelle Tai5, Srivatsan Raghavan6, Heather E Fleming7, Sangeeta N Bhatia8.   

Abstract

There is a critical need for the development of safe and efficient delivery technologies for CRISPR/Cas9 to advance translation of genome editing to the clinic. Non-viral methods that are simple, efficient, and completely based on biologically-derived materials could offer such potential. Here we report a simple and modular tandem peptide-based nanocomplex system with cell-targeting capacity that efficiently combines guide RNA (sgRNA) with Cas9 protein, and facilitates internalization of sgRNA/Cas9 ribonucleoprotein complexes to yield robust genome editing across multiple cell lines.

Entities:  

Mesh:

Year:  2019        PMID: 31670340      PMCID: PMC7709491          DOI: 10.1039/c9nr01786k

Source DB:  PubMed          Journal:  Nanoscale        ISSN: 2040-3364            Impact factor:   7.790


  59 in total

1.  Endosomal Escape and Delivery of CRISPR/Cas9 Genome Editing Machinery Enabled by Nanoscale Zeolitic Imidazolate Framework.

Authors:  Shahad K Alsaiari; Sachin Patil; Mram Alyami; Kholod O Alamoudi; Fajr A Aleisa; Jasmeen S Merzaban; Mo Li; Niveen M Khashab
Journal:  J Am Chem Soc       Date:  2017-12-27       Impact factor: 15.419

2.  Development of Light-Activated CRISPR Using Guide RNAs with Photocleavable Protectors.

Authors:  Piyush K Jain; Vyas Ramanan; Arnout G Schepers; Nisha S Dalvie; Apekshya Panda; Heather E Fleming; Sangeeta N Bhatia
Journal:  Angew Chem Int Ed Engl       Date:  2016-08-24       Impact factor: 15.336

3.  Tumor cell-targeted delivery of CRISPR/Cas9 by aptamer-functionalized lipopolymer for therapeutic genome editing of VEGFA in osteosarcoma.

Authors:  Chao Liang; Fangfei Li; Luyao Wang; Zong-Kang Zhang; Chao Wang; Bing He; Jie Li; Zhihao Chen; Atik Badshah Shaikh; Jin Liu; Xiaohao Wu; Songlin Peng; Lei Dang; Baosheng Guo; Xiaojuan He; D W T Au; Cheng Lu; Hailong Zhu; Bao-Ting Zhang; Aiping Lu; Ge Zhang
Journal:  Biomaterials       Date:  2017-09-13       Impact factor: 12.479

4.  Graphene oxide-mediated Cas9/sgRNA delivery for efficient genome editing.

Authors:  Huahua Yue; Xiaoming Zhou; Meng Cheng; Da Xing
Journal:  Nanoscale       Date:  2018-01-18       Impact factor: 7.790

5.  In Vivo Ovarian Cancer Gene Therapy Using CRISPR-Cas9.

Authors:  Zhi-Yao He; Ya-Guang Zhang; Yu-Han Yang; Cui-Cui Ma; Ping Wang; Wei Du; Ling Li; Rong Xiang; Xiang-Rong Song; Xia Zhao; Shao-Hua Yao; Yu-Quan Wei
Journal:  Hum Gene Ther       Date:  2018-02       Impact factor: 5.695

6.  Gesicle-Mediated Delivery of CRISPR/Cas9 Ribonucleoprotein Complex for Inactivating the HIV Provirus.

Authors:  Lee A Campbell; Lamarque M Coke; Christopher T Richie; Lowella V Fortuno; Aaron Y Park; Brandon K Harvey
Journal:  Mol Ther       Date:  2018-10-11       Impact factor: 11.454

7.  Highly efficient RNA-guided genome editing in human cells via delivery of purified Cas9 ribonucleoproteins.

Authors:  Sojung Kim; Daesik Kim; Seung Woo Cho; Jungeun Kim; Jin-Soo Kim
Journal:  Genome Res       Date:  2014-04-02       Impact factor: 9.043

8.  Cationic lipid-mediated delivery of proteins enables efficient protein-based genome editing in vitro and in vivo.

Authors:  John A Zuris; David B Thompson; Yilai Shu; John P Guilinger; Jeffrey L Bessen; Johnny H Hu; Morgan L Maeder; J Keith Joung; Zheng-Yi Chen; David R Liu
Journal:  Nat Biotechnol       Date:  2014-10-30       Impact factor: 54.908

9.  Highly efficient baculovirus-mediated multigene delivery in primary cells.

Authors:  Maysam Mansouri; Itxaso Bellon-Echeverria; Aurélien Rizk; Zahra Ehsaei; Chiara Cianciolo Cosentino; Catarina S Silva; Ye Xie; Frederick M Boyce; M Wayne Davis; Stephan C F Neuhauss; Verdon Taylor; Kurt Ballmer-Hofer; Imre Berger; Philipp Berger
Journal:  Nat Commun       Date:  2016-05-04       Impact factor: 14.919

10.  Tumor-Penetrating Delivery of siRNA against TNFα to Human Vestibular Schwannomas.

Authors:  Yin Ren; Jessica E Sagers; Lukas D Landegger; Sangeeta N Bhatia; Konstantina M Stankovic
Journal:  Sci Rep       Date:  2017-10-10       Impact factor: 4.379

View more
  10 in total

Review 1.  Perspectives on new opportunities for nano-enabled strategies for gene delivery to plants using nanoporous materials.

Authors:  Mohsen Niazian; Ayoub Molaahmad Nalousi; Pejman Azadi; Leila Ma'mani; Stephen F Chandler
Journal:  Planta       Date:  2021-09-24       Impact factor: 4.116

Review 2.  New approaches to moderate CRISPR-Cas9 activity: Addressing issues of cellular uptake and endosomal escape.

Authors:  Maja van Hees; Sofie Slott; Anders Højgaard Hansen; Heon Seok Kim; Hanlee P Ji; Kira Astakhova
Journal:  Mol Ther       Date:  2021-06-04       Impact factor: 11.454

Review 3.  Strategies in the delivery of Cas9 ribonucleoprotein for CRISPR/Cas9 genome editing.

Authors:  Song Zhang; Jiangtao Shen; Dali Li; Yiyun Cheng
Journal:  Theranostics       Date:  2021-01-01       Impact factor: 11.556

4.  Bi-functionalized aminoguanidine-PEGylated periodic mesoporous organosilica nanoparticles: a promising nanocarrier for delivery of Cas9-sgRNA ribonucleoproteine.

Authors:  Pardis Rahimi Salekdeh; Leila Ma'mani; Javad Tavakkoly-Bazzaz; Hossein Mousavi; Mohammad Hossein Modarressi; Ghasem Hosseini Salekdeh
Journal:  J Nanobiotechnology       Date:  2021-03-31       Impact factor: 10.435

Review 5.  Advanced Nanotheranostics of CRISPR/Cas for Viral Hepatitis and Hepatocellular Carcinoma.

Authors:  Huimin Kong; Enguo Ju; Ke Yi; Weiguo Xu; Yeh-Hsing Lao; Du Cheng; Qi Zhang; Yu Tao; Mingqiang Li; Jianxun Ding
Journal:  Adv Sci (Weinh)       Date:  2021-10-19       Impact factor: 16.806

6.  Rapid Assessment of CRISPR Transfection Efficiency and Enrichment of CRISPR Induced Mutations Using a Dual-Fluorescent Stable Reporter System.

Authors:  Karim E Shalaby; Mustapha Aouida; Vijay Gupta; Simona S Ghanem; Omar M A El-Agnaf
Journal:  Front Genome Ed       Date:  2022-03-21

Review 7.  Tissue-Specific Delivery of CRISPR Therapeutics: Strategies and Mechanisms of Non-Viral Vectors.

Authors:  Karim Shalaby; Mustapha Aouida; Omar El-Agnaf
Journal:  Int J Mol Sci       Date:  2020-10-05       Impact factor: 5.923

Review 8.  Peptide-Based Nanoparticles for Therapeutic Nucleic Acid Delivery.

Authors:  Prisca Boisguérin; Karidia Konate; Emilie Josse; Eric Vivès; Sébastien Deshayes
Journal:  Biomedicines       Date:  2021-05-20

Review 9.  Cell-Penetrating Peptides and Transportan.

Authors:  Ülo Langel
Journal:  Pharmaceutics       Date:  2021-06-29       Impact factor: 6.321

Review 10.  Genome editing via non-viral delivery platforms: current progress in personalized cancer therapy.

Authors:  Tianxia Lan; Haiying Que; Min Luo; Xia Zhao; Xiawei Wei
Journal:  Mol Cancer       Date:  2022-03-11       Impact factor: 27.401

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.